NewLink Genetics Corporation (NASDAQ:NLNK)

CAPS Rating: 2 out of 5

Results 1 - 7 of 7

Recs

0
Member Avatar pchop12316 (83.84) Submitted: 8/15/2014 10:48:38 AM : Underperform Start Price: $27.42 NLNK Score: +8.30

sell into this little rise in price

Recs

0
Member Avatar Dennyboy01 (33.64) Submitted: 1/13/2014 10:56:11 AM : Outperform Start Price: $25.18 NLNK Score: -6.47

This company appears to be on track in developing products to fight cancer and should be a good buyout candidate.

Recs

0
Member Avatar mdoyle3834 (< 20) Submitted: 1/8/2014 7:03:08 AM : Outperform Start Price: $22.76 NLNK Score: +4.03

Newlink is involved in pancreatic cancer drug research. The stock is lifting off.

Recs

1
Member Avatar zzlangerhans (99.77) Submitted: 4/30/2013 7:42:12 PM : Underperform Start Price: $12.40 NLNK Score: -80.77

I laid out the reasons why I think HyperAcute Pancreas will fail here in February: http://caps.fool.com/Pitch/NLNK/6662267/newlinks-most-advanced-clinica.aspx

After closing my prior underperform for a win I'm back in red and quickly down 12 points. This is a case where I hope I go negative as much as possible because NewLink in looking like a great candidate for puts prior to the interim data expected in mid-2013. I'll keep my ear to the ground for more specific information regarding the data release, which was already pushed back very quietly from April, and update this pitch with put prices and my position, if any.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:11:13 PM : Outperform Start Price: $17.18 NLNK Score: -1.36

porto. likededd it.

Recs

0
Member Avatar GregoryGK (< 20) Submitted: 6/16/2012 9:24:28 AM : Outperform Start Price: $15.80 NLNK Score: +13.06

High risk but potential high reward.

Recs

0
Member Avatar ta2122 (36.16) Submitted: 2/7/2012 2:59:17 PM : Underperform Start Price: $7.00 NLNK Score: -216.64

Never has had income. Now with more cash it will? No. Earnings move stocks, not charts.

Results 1 - 7 of 7

Featured Broker Partners


Advertisement